MBAI Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio1.36Forward 1.27
EPS (TTM)$4.650.0% YoY
Profit margin0.0%TECHNOLOGY
Market cap$96.8MMicro cap
Valuation
- Forward P/E
- 1.27
- PEG ratio
- —
- P/B
- 2.65
- P/S (TTM)
- —
- EV/EBITDA
- 2.04
Profitability & growth
- ROE (TTM)
- 41.7%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 0.82
Last earnings
Feb 25, 2026 · Estimate $0.00 · Reported $0.00
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Check-Cap Ltd.
Company profileCheck-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company is headquartered in Isfiya, Israel.
Classification
- Sector
- Technology
- Industry
- Software - Infrastructure
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 7111 SYNTEX DRIVE, MISSISSAUGA, ON
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Market cap$96.8M
Shares outstanding$15.3M
52W high$10.21
52W low$0.97
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent